EDGAR Filing Documents for 0001485003-17-000113

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001485003-17-000113

Filing Date

2017-10-30

Accepted

2017-10-30 07:45:41

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-1/A	ebioforms-1a22017xshortform.htm	S-1/A	594806
2	EXHIBIT 1.1	ex11ebio-underwritingagree.htm	EX-1.1	204829
3	EXHIBIT 4.6	ex46ebiopre-fundedwarrant1.htm	EX-4.6	106844
4	EXHIBIT 4.7	ex47ebiowarrant1rff10272017.htm	EX-4.7	108173
5	EXHIBIT 5.1	ex51opinionhogan.htm	EX-5.1	15491
6	EXHIBIT 23.1	ex231consentofey.htm	EX-23.1	2399
7	EXHIBIT 23.2	ex232consentofpwc.htm	EX-23.2	2907
8		ebiologoa30.jpg	GRAPHIC	89522
9		ebiologoa31.jpg	GRAPHIC	3986
10		hllogoa02.jpg	GRAPHIC	28096
	Complete submission text file	0001485003-17-000113.txt		1203863

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142

Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550

Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-220809 | Film No.: 171160684
SIC: 2834 Pharmaceutical Preparations